FDA Approves Cell Therapy for Blood Cancer Patients

Cell therapy has the potential to reduce the risk of infection after stem cell transplants. The U.S. Food and Drug Administration (FDA) recently approved Omisirge (omidubicel-onlv), a donor-modified…

Read More

FDA Study Reconsiders Blood Donation Restrictions

Blood shortage prompts reassessment of LGBTQ donation ban. The American Red Cross has seen a 10 percent drop in blood donations since the start of the pandemic, leading…

Read More

Back to top
FE3